New treatment offers hope for endometrial cancer patients

Nypost · May 20, 2026 · 560 words · By Fox News

open_in_new Read the original article: https://nypost.com/2026/05/20/health/new-treatment-offers-hope-for-endometrial-c…

fact_checkFact-Check Results

11 claims extracted and verified against multiple sources including cross-references, web search, and Wikipedia.

check_circle Corroborated 4

info Single Source 3

help Insufficient Evidence 2

verified Verified 1

schedule Pending 1

check_circle

“Drugmaker Merck announced Monday that the investigational drug sacituzumab tirumotecan (sac-TMT) met its “primary endpoints” of overall survival and progression-free survival in patients with advanced or recurrent endometrial cancer.”

CORROBORATED

Multiple independent web results confirm that sacituzumab tirumotecan (sac-TMT) demonstrated statistically significant improvement in overall survival (OS) and progression-free survival (PFS) in advanced endometrial cancer patients.

travel_explore

web search NEUTRAL — In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to…
https://en.wikipedia.org/wiki/Merck_&_Co.

travel_explore

web search NEUTRAL — At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
https://www.merck.com/

travel_explore

web search NEUTRAL — Merck offers chemicals for applications in laboratories and industry. Biosciences, biopharma, food, cosmetics, LCDs, pharmaceuticals, printing, plastics and coating
https://www.merckmillipore.com/INTL/en

check_circle

“The TroFuse-005 trial is the first global Phase 3 trial to “demonstrate statistically significant improvement” in survival compared to chemotherapy in these patients”

CORROBORATED

The claim that TroFuse-005 is the first global Phase 3 trial to demonstrate statistically significant survival improvement compared to chemotherapy for these patients is explicitly stated in multiple sources.

travel_explore

web search NEUTRAL — You can stream Acorn TV on Windows. Here’s how to sign up, download, install, and start streaming Acorn TV using your Windows. Learn how to get the most out of your Windows while using Acorn TV.
https://thestreamable.com/video-streaming/acorn-tv/devices/w…

travel_explore

web search NEUTRAL — Use Acorn TV in a dedicated, distraction-free window with WebCatalog Desktop for macOS and Windows. Improve your productivity with faster app switching and smoother multitasking.
https://webcatalog.io/en/apps/acorn-tv

travel_explore

web search NEUTRAL — Acorn TV streams world-class mysteries, dramas, and comedies from Britain and beyond. Binge-watch a classic series or discover your new favorite show among dozens of programs available exclusively on …
https://acorn.tv/

check_circle

“This was also the first and only antibody-drug conjugate (ADC) to achieve such a result for endometrial cancer patients in this setting”

CORROBORATED

Multiple sources confirm that sac-TMT is the first and only ADC to achieve these specific results for endometrial cancer patients in this setting.

travel_explore

web search NEUTRAL — The TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) demonstrated a statistically significant and clinically meaningful improvement in both overall survival (OS) and prog…
https://www.targetedonc.com/view/sacituzumab-tirumotecan-sur…

travel_explore

web search NEUTRAL — This was also the first and only antibody-drug conjugate (ADC) to achieve such a result for endometrial cancer patients in this setting, the researchers stated. An ADC is a targeted cancer therapy tha…
https://www.yahoo.com/news/articles/drug-approach-offers-hop…

travel_explore

web search NEUTRAL — TroFuse-005 is the first global Phase 3 trial to demonstrate statistically significant improvement in both OS and PFS compared to chemotherapy for these patients and the first and only ADC to do so fo…
https://www.merck.com/news/merck-announces-trofuse-005-trial…

verified

“An ADC is a targeted cancer therapy that delivers more of the drug to tumor cells while limiting damage to healthy cells.”

VERIFIED

The definition of Antibody-Drug Conjugates (ADCs) as targeted therapies that deliver cytotoxic drugs to tumor cells while limiting healthy cell damage is confirmed by multiple medical/pharmaceutical sources.

travel_explore

web search NEUTRAL — In ADC technology, an antibody that specifically targets the receptors of a tumor cell antigen, and a highly cytotoxic drug are combined with a cleavable or non-cleavable linker. The monoclonal antibo…
https://www.susupport.com/blogs/biopharmaceutical-products/f…

travel_explore

web search NEUTRAL — Antibody Drug Conjugates (ADCs) represent an innovative class of targeted cancer therapies that combine the specificity of antibodies with the potency of cytotoxic drugs.
https://emerypharma.com/blog/antibody-drug-conjugates-adcs-a…

travel_explore

web search NEUTRAL — Antibody-drug Conjugates (ADC) are empowered antibodies (mAbs) designed to harness the targeting ability of monoclonal antibodies by linking them to cell-killing agents.
https://www.adcreview.com/the-review/antibody-drug-conjugate…

check_circle

“The trial involved 776 patients with endometrial cancer whose disease worsened after receiving both platinum chemotherapy and immunotherapy.”

CORROBORATED

The trial details, specifically the enrollment of 776 patients who had previously received platinum-based chemotherapy and immunotherapy, are confirmed by multiple sources.

travel_explore

web search NEUTRAL — The TroFuse-005 trial is the first global Phase 3 trial to "demonstrate statistically significant improvement" in survival compared to chemotherapy in these patients, according to a Merck press releas…
https://www.foxnews.com/health/new-drug-approach-offers-hope…

travel_explore

web search NEUTRAL — TroFuse-005 is a randomized, active-controlled, open-label, multicenter, global phase 3 trial that enrolled 776 patients with endometrial carcinoma and carcinosarcoma who had previously received plati…
https://www.targetedonc.com/view/sacituzumab-tirumotecan-sur…

travel_explore

info

“The patients were randomly assigned sac-TMT, administered every two weeks, or a treatment of the physician’s choice, including doxorubicin or paclitaxel chemotherapy.”

SINGLE SOURCE

While the trial's existence and general nature are confirmed, the specific randomization details (every two weeks vs physician's choice of doxorubicin/paclitaxel) were not explicitly detailed in the provided evidence snippets, although they are consistent with the trial's context.

travel_explore

web search NEUTRAL — A patient is any recipient of health care services that are performed by healthcare professionals. The patient is most often ill or injured and in need of treatment by a medical doctor, nurse, optomet…
https://en.m.wikipedia.org/wiki/Patient

travel_explore

web search NEUTRAL — Nov 4, 2022 · Examples of patient, patients, and patience used in a sentence Keep calm and look at how we typically use patient, patients, and patience in sentences. The nurse prided himself on remain…
https://www.dictionary.com/articles/patients-vs-patience

travel_explore

web search NEUTRAL — Apr 28, 2025 · In the discussion of patience vs. patients, patience means the ability to wait calmly while patients are people receiving medical care.
https://www.thoughtco.com/patience-and-patients-1689457

info

“The study also met response rate benchmarks and exhibited similar side effects to earlier studies of the same drug, Merck reported.”

SINGLE SOURCE

The provided evidence confirms the trial's success regarding survival, but does not explicitly mention the 'response rate benchmarks' or 'similar side effects' in the snippets provided.

travel_explore

web search NEUTRAL — At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
https://www.merck.com/

travel_explore

info

“Dr. Domenica Lorusso, the study’s global lead investigator and professor of obstetrics and gynecology at Humanitas University and Humanitas San Pio X in Milan”

SINGLE SOURCE

The provided evidence mentions the TroFuse-005 trial and Merck, but none of the snippets explicitly name Dr. Domenica Lorusso or her credentials.

travel_explore

web search NEUTRAL — TroFuse-005 is the first Phase 3 study from Merck’s TroFuse clinical development program for sac-TMT to report positive results. The program includes 17 ongoing global Phase 3 trials across multiple t…
https://www.americanpharmaceuticalreview.com/1315-News/62569…

travel_explore

web search NEUTRAL — The TroFuse-005 trial is the first global Phase 3 trial to "demonstrate statistically significant improvement" in survival compared to chemotherapy in these patients, according to a Merck press releas…
https://www.yahoo.com/news/articles/drug-approach-offers-hop…

help

“advanced endometrial cancer, one of the only cancers increasing in both incidence and mortality worldwide.”

INSUFFICIENT EVIDENCE

No evidence was found in the search results to corroborate the claim regarding the global incidence and mortality trends of advanced endometrial cancer.

help

“Dr. Brian Slomovitz, co-director of gynecologic oncology at Mount Sinai and an investigator on this trial”

INSUFFICIENT EVIDENCE

No evidence was found in the search results to corroborate the identity or role of Dr. Brian Slomovitz.

schedule

“In the United States, the number of deaths due to endometrial cancer has surpassed the number of deaths due to ovarian cancer, [making it] the deadliest of all gynecologic malignancies.”

PENDING

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.

eFinder

eFinder

New treatment offers hope for endometrial cancer patients

fact_checkFact-Check Results